December 2021

Kanyakumari District Sunniyakumari District Health Association - Applications are invited to work on the following vacancies in the National Tuberculosis Prevention Program on 11 month contract basis on package pay.

Post : District Pharmacist

Applications are invited through offline mode (Physical applications) from the eligible candidates for recruitment to the below mentioned posts on Contract / Outsourcing basis under the control of Director of Medical Education to work in Government Maternity Hospital, Tirupati, Chittoor district.

Post : Pharmacist Gr-II

Coral Laboratories Ltd. is one of the most fastest growing Pharmaceutical company for exports. We are fully equipped with required facilities to develop formulations that are bio-equivalent, safe & efficacious. Coral Laboratories Limited produces various pharmaceutical formulations at three different locations all over India.

Sunlovis Pharmaceuticals is a Fast Growing Pharmaceuticals Company with a Strong Focus on supply of good Quality yet Affordable Medicine in India and across the World and is a Trusted Name among the Healthcare Professionals.  Sunlovis Competitive Advantage Steps From the World Class Manufacturing Facilities. We have a sharp Focus on giving Value added Services to our customer cost effectively. We offer a Strong Product Portfolio Spanning in Beta-lactam Categories.

Accuprec Research Labs Pvt Ltd. is FDCA approved, NABL accredited and ISO 9001:2015 certified CRO. Head Quarter of the CRO is located at Ahmedabad and branch offices at Canada and USA. Accuprec provides all type of Pharmaceutical testing solutions to its domestic and MNC clients.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

BIO BULK MANUFACTURING
Cell Culture - Upstream / Downstream Microbial - Downstream

Dr. Bowen Li is an incoming Tenure-Stream Assistant Professor of Pharmaceutical Sciences at the University of Toronto (starting Jan 2022). He is currently a postdoctoral associate at MIT, working with Professor Robert Langer and Professor Daniel Anderson. His current research is focused on employing engineering approaches to enhance the performance of mRNA-based therapeutics and vaccines for combating cancer and infection diseases.

Post : Postdoctoral Fellow Position

Vifor Pharma announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult patients with sickle cell disease. Vamifeport, developed by Vifor Pharma, is a novel oral ferroportin inhibitor investigated for treatment of diseases characterized by ineffective production of red blood cells and iron overload, including SCD and beta-thalassemia. It has been granted orphan drug designation from both the U.S.

Vifor Pharma and Angion Biomedica Corp announced results from the exploratory phase-II GUARD trial of Angion’s ANG-3777 in patients undergoing cardiac surgery involving cardiopulmonary bypass at risk for developing acute kidney injury (CSA-AKI). The trial did not meet its primary endpoint of percentage increase in serum creatinine based upon the area under the curve (AUC). However, Angion and Vifor Pharma continue to review the data, based on the signal demonstrated in the clinically-relevant MAKE90 secondary endpoint.